Manual polybrene method for pretransfusion test could overcome the interference of daratumumab therapy in myeloma

Transfusion. 2019 Aug;59(8):2751-2752. doi: 10.1111/trf.15341.

Authors

Tsung-Jang Yeh^{1

2}, Chi-Jung Yeh³, Yi-Chang Liu^{2

4}, Hui-Hua Hsiao^{2

3

4}

Affiliations

¹ Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
² Division of Hematology-Oncology, Department of Internal medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
³ Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
⁴ Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

PMID: 31374150
DOI: 10.1111/trf.15341

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal* / administration & dosage
Antibodies, Monoclonal* / pharmacokinetics
Blood Grouping and Crossmatching*
Blood Transfusion*
Hexadimethrine Bromide / chemistry*
Humans
Multiple Myeloma* / blood
Multiple Myeloma* / therapy

Substances

Antibodies, Monoclonal
Hexadimethrine Bromide
daratumumab